-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, P3qHQyNdsuR3xm14rWPlvTv6dIxgTeaWAn3WGidMBytkCjaIanoc78P5/oUuFMaj oEkRQH1CroCLLPkMaTlV3A== 0001125282-06-003150.txt : 20060601 0001125282-06-003150.hdr.sgml : 20060601 20060601141127 ACCESSION NUMBER: 0001125282-06-003150 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20060530 FILED AS OF DATE: 20060601 DATE AS OF CHANGE: 20060601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wires David E CENTRAL INDEX KEY: 0001363878 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 06879576 BUSINESS ADDRESS: BUSINESS PHONE: 416-366-4006 MAIL ADDRESS: STREET 1: WIRES JOLLEY LLP STREET 2: 90 ADELAIDE STREET WEST, SUITE 200 CITY: TORONTO STATE: A6 ZIP: M5H3V9 3 1 form.xml X0202 3 2006-05-30 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001363878 Wires David E WIRES JOLLEY LLP 90 ADELAIDE STREET WEST, SUITE 200 TORONTO, ONTARIO, CANADA M5H3V9 1 Common Stock 164300 D Common Stock 7539 I By Limited Liability Partnership 14,300 shares are held in a registered retirement saving plan beneficially owned by the reporting person and 150,000 shares are restricted Common Stock awarded to the reporting person on 5/30/2006 following the reporting person's election as director of Generex Biotechnology Corporation on the same date. The restricted Common Stock was awarded pursuant to Generex Biotechnology Corporation's 2006 Stock Plan. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. /s/ Elizabeth M. Simon, as attorney-in-fact for David E. Wires 2006-06-01 EX-24 2 k0325231.htm e7be249fb54fb753bca2036abae46cff.doc

POWER OF ATTORNEY


  KNOW ALL MEN BY THESE PRESENTS, that I, David E. Wires, have made, constituted and appointed and by these presents do hereby make, constitute and appoint each of Elizabeth M. Simon, Briar L. McNutt and Gary Miller, acting singly, my true and lawful attorney-in-fact to:


(1) execute for and on my behalf, in my capacity as an officer and/or director of Generex Biotechnology Corporation, Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder and any other forms or reports that I may be required to file in connection with my ownership, acquisition or disposition of securities of Generex Biotechnology Corporation;


(2) do and perform all and every act for and on my behalf which may be necessary or desirable to complete the execution of any such Form 3, 4 or 5, or other form or report, and the timely filing of such form with the United States Securities and Exchange Commission and any other authority as required by the Securities Exchange Act of 1934, as amended, and the rules thereunder; and


(3) take any other action whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, me, it being understood that the documents executed by such attorney-in-fact on my behalf pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in his discretion.


  I hereby grant to such attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite and necessary to be done in the exercise of any of the rights and powers herein granted, as fully, to all intents and purposes as I might or could do if personally present, with full power of substitution and revocation, hereby ratifying and confirming all that such attorney-in-fact, or his substitute or substitutes, shall lawfully do or cause to be done by virtue thereof. I acknowledge that the foregoing attorney-in-fact, in serving in such capacity at my request, is not assuming, nor is Generex Biotechnology Corporation assuming, any of my responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended.


  This Power of Attorney shall remain in full force and effect until I am no longer required to file Forms 3, 4 and 5 with respect to my holdings of and transactions in securities issued by Generex Biotechnology Corporation, unless earlier revoked by me in a signed writing delivered to Eckert Seamans Cherin & Mellott, LLC.


  IN WITNESS WHEREOF, I have caused this Power of Attorney to be executed as of this 23 day of May, 2006.


WITNESS:


/s/ Katharine Rockingham    /s/ David E. Wires           Signature


       David E. Wires    

       Print Name


-----END PRIVACY-ENHANCED MESSAGE-----